FIELD: pharmaceutics.
SUBSTANCE: invention relates to 4-aminomethyl heliomycin derivatives corresponding to the formula:
as well as to pharmaceutical compositions based on them.
EFFECT: technical result: new compounds are obtained with the ability to inhibit the division of tumor cells.
6 cl, 18 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL HELIOMYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF INHIBITING TUMOR GROWTH | 2018 |
|
RU2670763C1 |
| DERIVATIVES OF 1,4-DIOXIDE OF QUINOXALINE-2-CARBONITRILE INHIBITING TUMOUR CELLS GROWTH | 2016 |
|
RU2640304C1 |
| METHOD FOR INHIBITING TUMOR CELLS WITH NEW DERIVATIVES OF 3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDE | 2020 |
|
RU2746395C1 |
| MULTITARGET INHIBITORS OF TUMOUR GROWTH BASED ON LINEAR HETEROARENE ANTHRACENEDIONES | 2013 |
|
RU2527273C1 |
| NEW HETEROARENANTHRACENE-2-CARBOXAMIDE DERIVATIVES INHIBITING TUMOUR GROWTH | 2016 |
|
RU2631100C1 |
| QUATERNARY AMMONIUM SALTS BASED ON DERIVATIVES OF VITAMIN B6 | 2015 |
|
RU2607522C1 |
| SUBSTITUTED ISOXAZOLES, PHARMACEUTICAL COMPOSITIONS BASED THEREON HAVING ANTIVIRAL ACTIVITY, AND METHOD FOR USE THEREOF | 2018 |
|
RU2733945C2 |
| LIGANDS, TROPIC TO PROSTATIC SPECIFIC MEMBRANE ANTIGEN AND USE THEREOF FOR OBTAINING DOUBLE CONJUGATES WITH THERAPEUTIC AGENTS BASED THEREON FOR COMBINED THERAPY OF PSMA EXPRESSING TUMOURS | 2023 |
|
RU2841078C1 |
| PYRIDOXINE DERIVATIVE-BASED BETA-ADRENERGIC BLOCKING AGENTS | 2014 |
|
RU2569900C1 |
| PYRIDOXIN AND ACETONE DERIVATIVES WITH ANTITUMOR ACTIVITY | 2017 |
|
RU2639879C1 |
Authors
Dates
2018-02-14—Published
2016-06-28—Filed